Back to top

Arcosa downgraded to Perform from Outperform at Oppenheimer

Oppenheimer downgraded Arcosa (ACA) to Perform from Outperform without a price target after the company agreed to be acquired by CRH in an all-cash...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Arcosa, Inc. (ACA)